Shoulder Innovations (NYSE:SI) CFO Jeffrey Points Buys 1,600 Shares

Shoulder Innovations, Inc. (NYSE:SIGet Free Report) CFO Jeffrey Points bought 1,600 shares of the stock in a transaction that occurred on Friday, September 12th. The shares were bought at an average price of $15.67 per share, for a total transaction of $25,072.00. Following the completion of the transaction, the chief financial officer directly owned 52,445 shares of the company’s stock, valued at $821,813.15. This represents a 3.15% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink.

Shoulder Innovations Trading Down 4.7%

Shares of NYSE:SI opened at $14.97 on Tuesday. Shoulder Innovations, Inc. has a 1-year low of $11.75 and a 1-year high of $17.94. The company has a market cap of $227.98 million and a price-to-earnings ratio of -0.50.

Analyst Ratings Changes

A number of equities research analysts have issued reports on SI shares. Wall Street Zen raised shares of Shoulder Innovations from a “sell” rating to a “hold” rating in a report on Saturday. Morgan Stanley assumed coverage on Shoulder Innovations in a report on Monday, August 25th. They set an “overweight” rating and a $18.00 price objective on the stock. Piper Sandler assumed coverage on Shoulder Innovations in a report on Monday, August 25th. They set an “overweight” rating and a $18.00 price objective on the stock. Jefferies Financial Group assumed coverage on Shoulder Innovations in a report on Monday, August 25th. They set a “buy” rating and a $19.00 price objective on the stock. Finally, Zacks Research raised Shoulder Innovations to a “hold” rating in a report on Tuesday, August 26th. Five research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $19.60.

Check Out Our Latest Report on SI

Shoulder Innovations Company Profile

(Get Free Report)

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.

Recommended Stories

Insider Buying and Selling by Quarter for Shoulder Innovations (NYSE:SI)

Receive News & Ratings for Shoulder Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shoulder Innovations and related companies with MarketBeat.com's FREE daily email newsletter.